Small Molecules for Precision Medicine

Learn More about Arqule

We are pursuing multiple programs in biomarker-defined oncology and rare disease indications

Targeted Approach to Cancer

Clinical Trials

Learn More

Research & Development

Product Pipeline

Explore

Targeted Approach To

Rare Diseases

Read More

News & Events

September 29, 2017
Proteus Syndrome Phase 1 Data Presentation
Watch Video »
November 13, 2019
ArQule to Participate in the Jefferies London Healthcare Conference on November 20, 2019
Read More »
November 6, 2019
ArQule Announces Release of American Society of Hematology Abstract Detailing Results of the Ongoing Phase 1 Study of Reversible BTK Inhibitor, ARQ 531, in Patients with Relapsed/Refractory Hematologic Malignancies
Read More »

More News & Events »

arqule

© Copyright ArQule. All rights reserved. Terms of Use.